ArticleCentral European journal of urology2014

What is the feasibility of switching to 200IU OnabotulinumtoxinA in patients with detrusor overactivity who have previously received 300IU?

Manar Malki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.